NCT07152171

Brief Summary

Chronic musculoskeletal pain is a common health condition that reduces quality of life and increases disability. Pain neuroscience education (PNE) has shown positive effects on pain perception, beliefs, and function, especially when combined with physical activity. This randomized controlled trial will compare the effectiveness of delivering PNE during aerobic exercise on a cycle ergometer versus aerobic exercise alone in patients with chronic musculoskeletal pain. Participants will be randomly assigned to one of two groups: PNE during aerobic exercise (experimental group), Aerobic exercise alone (control group). Both groups will perform supervised cycling sessions lasting 20-30 minutes at light intensity (Borg CR10 = 3, 40-50% HRmax). The experimental group will simultaneously receive interactive education about pain mechanisms, central sensitization, and self-management strategies, supported by visual aids and metaphors delivered by a therapist during cycling. Outcomes will be measured at baseline and after the intervention, including: Pain intensity (Visual Analog Scale), Pressure pain threshold (algometry), Functional performance (Sit-to-Stand test), Safety and comfort (Likert scale), The study will enroll 24 participants (12 per group). The findings are expected to clarify whether integrating education with exercise provides superior benefits compared to exercise alone, offering an innovative, safe, and cost-effective strategy for managing chronic musculoskeletal pain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 21, 2025

Completed
4 days until next milestone

Study Start

First participant enrolled

August 25, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 3, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2026

Completed
Last Updated

February 27, 2026

Status Verified

February 1, 2026

Enrollment Period

5 months

First QC Date

August 21, 2025

Last Update Submit

February 25, 2026

Conditions

Keywords

Musculoskeletal PainPain Neuroscience EducationAerobic ExercisePhysical TherapyRehabilitation

Outcome Measures

Primary Outcomes (1)

  • Change in Pain Intensity (Visual Analog Scale, 0-10)

    Pain intensity will be assessed using a 10-cm Visual Analog Scale (VAS; 0 = no pain, 10 = worst imaginable pain). The primary endpoint is the change score (post-session minus baseline). Higher scores indicate greater pain.

    Baseline (pre-session) and immediately post-intervention (within 30 minutes)

Secondary Outcomes (3)

  • Change in Pressure Pain Threshold (kgf) by Algometry

    Pressure pain threshold (PPT) will be measured at the most symptomatic lumbar region using a handheld algometer. Pressure is increased at a constant rate until the participant first perceives pain; the value (kgf) is recorded. The outcome is the change s

  • Change in Functional Performance (30-Second Sit-to-Stand Test)

    Participants sit on a standard chair (≈43 cm height) with arms crossed and stand up/sit down as many times as possible in 30 seconds. The total number of full stands is recorded. The outcome is the change in repetitions from baseline.

  • Safety and Comfort Ratings (Likert Scales)

    Immediately post-intervention (within 30 minutes)

Study Arms (2)

Pain Neuroscience Education During Aerobic Exercise

EXPERIMENTAL

Participants will perform 20-30 minutes of supervised aerobic exercise on a cycle ergometer at light intensity (Borg CR10 = 3; 40-50% HRmax). During cycling, they will receive interactive pain neuroscience education covering neurobiology of pain, central sensitization, and self-management strategies. Education will be delivered by a therapist using metaphors and visual aids to facilitate understanding while exercising.

Behavioral: Pain Neuroscience Education During Aerobic Exercise

Aerobic Exercise Alone

ACTIVE COMPARATOR

Participants will perform 20-30 minutes of supervised aerobic exercise on a cycle ergometer at light intensity (Borg CR10 = 3; 40-50% HRmax). No educational content will be provided. Sessions include warm-up, main cycling phase, and cool-down. Exercise parameters (cadence, resistance, and effort perception) will be matched to the experimental group.

Behavioral: Aerobic Exercise Alone

Interventions

Participants will cycle on an ergometer for 20-30 minutes at light intensity (Borg CR10 = 3; 40-50% HRmax). During cycling, they will receive interactive pain neuroscience education delivered by a therapist, including neurobiology of pain, central sensitization, and self-management strategies. Visual aids and metaphors will be used to facilitate understanding.

Pain Neuroscience Education During Aerobic Exercise

Participants will perform 20-30 minutes of supervised cycling on an ergometer at light intensity (Borg CR10 = 3; 40-50% HRmax). No educational content will be provided. Sessions will include warm-up, main phase, and cool-down, matched in duration and intensity to the experimental group.

Aerobic Exercise Alone

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18 to 65 years.
  • Diagnosis of chronic low back pain lasting ≥ 12 weeks.
  • Baseline pain intensity ≥ 4/10 on the Visual Analog Scale (VAS).
  • Able to perform light to moderate aerobic exercise
  • Willing and able to provide informed consent.

You may not qualify if:

  • Inability to understand or follow instructions.
  • Pregnancy.
  • Active cancer diagnosis.
  • Neurological disorders affecting the central nervous system (e.g., stroke).
  • Participation in alternative or concurrent therapies for pain management.
  • History of major orthopedic trauma or surgery in the last 12 months.
  • Any medical contraindication to light exercise identified during the medical screening.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Clínico Universidad de Chile

Santiago, Chile

Location

MeSH Terms

Conditions

Musculoskeletal Pain

Interventions

Exercise

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcome assessors will be blinded to group allocation. Participants and care providers cannot be blinded due to the nature of the intervention.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a two-arm, single-center randomized controlled trial with parallel assignment. Participants with chronic low back pain will be randomized (1:1) to receive either pain neuroscience education delivered during aerobic cycling exercise or aerobic exercise alone. Outcome assessors will be blinded to group allocation.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor, PhD

Study Record Dates

First Submitted

August 21, 2025

First Posted

September 3, 2025

Study Start

August 25, 2025

Primary Completion

January 15, 2026

Study Completion

January 15, 2026

Last Updated

February 27, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations